Combining pathway and bioactivity data for new insights

The possibility of finding and combining pathway information with known or predicted bioactivities has given rise to a powerful analytic method with considerable potential.

Combining pathway and bioactivity data for new insights

Access to high-quality compound bioactivity and physicochemical data, as well as information about biological pathways and potential drug targets, is more readily available to researchers than ever—and analytical methods have also been developed to help draw insights from this data. This fusion of information and tools now enables researchers to combine pathway and bioactivity data to create predictive models of compound behavior to support early drug discovery.

Read this white paper to discover how researchers can combine this data to:

  • Find new indications for an existing drug
  • Generate new target ideas with possible test compounds
  • Predict the adverse event potential of a compound

Read the white paper.

To access the complimentary white paper 'Combining pathway and bioactivity data for new insights', please fill in the form below.

Elsevier's R&D Solution supporting 'Combining Pathway and Bioactivity Data for New Insights'

Professional Services

Drive innovative pharmaceutical research by resolving challenges with data quality and integration and making data easier for researchers to compare, analyze, interpret and share.

Learn more about Professional Services
Contact a Professional Services expert